In the last trading session, 2.66 million shares of the Jaguar Health Inc (NASDAQ:JAGX) were traded, and its beta was 1.04. Most recently the company’s share price was $0.23, and it changed around -$0.02 or -7.23% from the last close, which brings the market valuation of the company to $3.79M. JAGX currently trades at a discount to its 52-week high of $21.60, offering almost -9291.3% off that amount. The share price’s 52-week low was $0.22, which indicates that the current value has risen by an impressive 4.35% since then. We note from Jaguar Health Inc’s average daily trading volume that its 10-day average is 40910.0 shares, with the 3-month average coming to 477.50K.
Jaguar Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended JAGX as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Jaguar Health Inc is expected to report earnings per share of -0.74 for the current quarter.
Jaguar Health Inc (NASDAQ:JAGX) trade information
Instantly JAGX has showed a red trend with a performance of -7.23% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4982 on recent trading dayincreased the stock’s daily price by 53.83%. The company’s shares are currently down -77.13% year-to-date, but still down -48.09% over the last five days. On the other hand, Jaguar Health Inc (NASDAQ:JAGX) is -73.79% down in the 30-day period. We can see from the shorts that 38122.0 shares have been sold at a short interest cover period of 2.57 day(s).
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 3.13M in revenue for the current quarter. 1 analysts expect Jaguar Health Inc to make 3.29M in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at 39.94%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 86.10%. Jaguar Health Inc earnings are expected to increase by 99.26% in 2025, but the outlook is positive 79.17% per year for the next five years.
JAGX Dividends
Jaguar Health Inc’s next quarterly earnings report is expected to be released on 2024-Nov-12.
Jaguar Health Inc (NASDAQ:JAGX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 14.81% of Jaguar Health Inc shares, and 1.71% of them are in the hands of institutional investors. The stock currently has a share float of 2.01%.
Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 59.5 shares worth $13745.0, making up 0.36% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 50.91 shares worth around $11759.0, which represents about 0.31% of the total shares outstanding.
